GCP
LHDX

GSA Capital Partners’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

GSA Capital Partners’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,516
Closed -$49K – 1991
2022
Q2 		$49K Buy
26,516
+12,750
+93% +$31K 0.01% 1291
2022
Q1 		$49K Buy
+13,766
New +$67.6K 0.01% 1339

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return

GSA Capital Partners's LHDX Position: Q3 2022 in Review

GSA Capital Partners sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 26,516 shares — an estimated $49K sold.

GSA Capital Partners first reported a position in LHDX in Q1 2022 and held it in 2 quarters. The position peaked at $49K in Q2 2022. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • GSA Capital Partners reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • GSA Capital Partners sold 26,516 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $49K.
  • GSA Capital Partners first reported a position in Lucira Health, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • GSA Capital Partners's Lucira Health, Inc. Common Stock position peaked at $49K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.